Werlabs has raised $4.0M in total across 1 funding round.
Werlabs's investors include Heartcore Capital.
Werlabs is a Swedish health technology company founded in 2013 that provides accessible, technology-driven blood testing and health check services to individuals and corporations. Their platform enables users to order comprehensive blood analysis packages online, visit one of over 200 testing locations across Sweden, and receive detailed, personalized health reports. Werlabs aims to empower people with actionable health insights to promote preventive healthcare and better personal well-being. The company has analyzed over 8.5 million blood markers and served more than 300,000 individuals, demonstrating strong growth and adoption in the health-tech space[1][2][6].
The idea for Werlabs emerged from the founders' vision to make health monitoring more accessible and user-friendly through digital tools and certified laboratory partnerships. Early traction came from their ability to combine medical expertise with a seamless online experience, allowing users to take control of their health with scientifically backed data. Their CEO, Henrik Forsberg, leads a team dedicated to expanding health check accessibility and innovation in Sweden[2][3].
Werlabs rides the growing trend of digital health and personalized medicine, where consumers increasingly demand convenient, data-driven health insights. The timing is favorable due to rising awareness of preventive healthcare, advances in medical diagnostics, and digital transformation in healthcare delivery. Market forces such as increased health consciousness, aging populations, and employer interest in employee wellness programs support Werlabs' growth. By integrating technology with certified lab services, Werlabs influences the ecosystem by setting standards for accessible, scalable health screening and empowering individuals with control over their health data[2][6].
Looking ahead, Werlabs is positioned to expand its offerings with subscription models and enhanced B2B services targeting mid-sized companies seeking to improve workplace health. Trends like telehealth, AI-driven diagnostics, and personalized wellness will likely shape their product evolution. Their composable tech stack provides flexibility to innovate rapidly and scale. As preventive healthcare gains further traction globally, Werlabs could extend beyond Sweden, influencing broader health-tech markets by demonstrating how technology can democratize access to vital health information.
In summary, Werlabs exemplifies a modern health-tech company leveraging technology and data to transform how individuals and organizations approach health monitoring and prevention.
Werlabs has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in August 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2016 | $4.0M Series A | Heartcore Capital |
